Prot #HCRN GI17-319/NU UNC19I02: A Single Arm, Multi-Center Phase 2 Trial of mFOLFOX6 + Trastuzumab + Avelumab in First-Line, Metastatic, HER2-Amplified Gastric and Esophageal Adenocarcinomas

Project: Research project

Project Details

StatusActive
Effective start/end date8/12/19 → 8/12/22

Funding

  • Hoosier Cancer Research Network, Inc. (Prot #HCRN GI17-319/NU UNC19I02)
  • EMD Serono Research & Development Institute, Inc. (Prot #HCRN GI17-319/NU UNC19I02)
View all
View less